Difmoc-g and use thereof in prevention and treatment of inflammation-related diseases
WO2026123198A1PCT designated stage Publication Date: 2026-06-18PLA NAVAL MEDICAL UNIVERSITY
Patent Information
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- PLA NAVAL MEDICAL UNIVERSITY
- Filing Date
- 2024-12-10
- Publication Date
- 2026-06-18
Smart Images
Figure PCTCN2024138099-FTAPPB-I100001 
Figure PCTCN2024138099-FTAPPB-I100002 
Figure PCTCN2024138099-FTAPPB-I100003
Abstract
DiFMOC-G and use thereof in the prevention and treatment of inflammation-related diseases. Use of DiFMOC-G or a pharmaceutically acceptable derivative, salt, or ester thereof in the preparation of a drug for treating inflammation-related diseases, use of DiFMOC-G or a pharmaceutically acceptable derivative, salt, or ester thereof in the preparation of a drug for preventing inflammation-related diseases, use of DiFMOC-G or a pharmaceutically acceptable derivative, salt, or ester thereof in the preparation of a drug for regulating an immune response, and use of DiFMOC-G or a pharmaceutically acceptable derivative, salt, or ester thereof in the preparation of a drug for treating autoimmune diseases.
Need to check novelty before this filing date? Find Prior Art